Pictured: CSL manufacturing employee in Australia

Senior Medical Director, Global Clinical Program Lead - Immunoglobulins

Einheit: CSL Behring

Jobkategorie: Physicians

Jobfamilie: Research & Medical Affairs

Beschäftigungsart: Full Time

Location: Maidenhead, England, United Kingdom

Arbeitgeberreferenz: R-293920

CSL Behring

Stellenbeschreibung

Position Overview:


The Senior Medical Director, Global Clinical Program Leader (GCPL) is a critical role within Clinical Development. The Senior GCPL is

accountable for the design and execution of the clinical strategy to support the development of a medicine, aligned with the Project Strategy Document (PSD) and the Target Product Profile (TPP). The GCPL is accountable for the strategic leadership of the Clinical Development Team (CDT) in a matrixed environment. Reports to the Global Clinical Lead (GCL).


Work Environment:


*** This is a hybrid position based onsite at any of the posted locations with a minimum of 3 days onsite weekly.  Relocation assistance and visa sponsorship are not provided.

Key Resonsibilities:


Clinical Development Team (CDT) Leadership:


  • Provides leadership and guidance to all members of the cross-functional CDT acting as the lead scientific expert for the clinical program, while ensuring appropriate functional representation in team discussions
  • accountable for the timely development and maintenance of the Clinical Development Plan (CDP) in alignment with the Program Strategy Team (PST) and Therapeutic Area Leadership Team (TALT)
  • Leads the integration of internal and external expert contributions to strategy and design of the assigned clinical program(s)
  • Maintaining alignment across critical stakeholders prior to key decision making forums (e.g. Strategic Development Committee (SDC) or Scientific and Technical Review Committee (STRC) for study outline approval)
  • Ensures that the program is conducted in alignment with CSL Behring processes and abiding by GCP and ICH regulations
  • Responsible for driving and documenting decision making within the CDT, facilitating issue resolution and escalation, as well as contingency planning

Clinical & Scientific Oversight:


  • Accountable for the clinical content for all CDT deliverables to ensure safe, efficient, timely and quality execution of assigned clinical programs
  • Ensures high quality clinical and scientific standards are met throughout all aspects of the program
  • Serves as the clinical development representative on the required cross-functional teams, including but not limited to the Study Execution Team (SET), Safety Management Team (SMT), the Benefit-Risk Assessment Team (BRAT), the Biomarker Expert Team (BET), and the Evidence and Access Strategy Team (EAST) for assigned programs
  • Develops and executes the Medical Monitoring Plan (MMP) strategy
  • Typically serves as the medical monitor for clinical trials during study conduct or provides oversight to assigned medical monitors
  • Presents results to Safety Monitoring Committee and other internal and external meetings
  • May participate or lead Due Diligence projects in support of CSL’s external innovation efforts

Document Authorship:


  • Reviews the data generated during the planning and execution of a study to gather a clinical understanding of the safety and efficacy results and the impact of the data on ongoing R&D strategies and provides support in defining the development strategy
  • “Lead Author” or “Contributing” Author for key study documents, including but not limited to: the TPP, PSD, CDP, Study Concept Scenarios, Study Outlines, the Investigator Brochure (IB), Clinical Study Protocols (CSP), Master Informed Consent Forms (ICF), Medical Monitoring Plans (MMP), Safety Review Committee (SRC)/Independent Data Monitoring Committee (IDMC) Charters, and Clinical Study Reports (CSR)
  • Leads preparations of clinical sections of relevant regulatory interaction packages including but not limited to briefing books, INDs, NDAs. BLAs, ODDs, RFIs, and routine reporting
  • Contributing author the publication strategy. Author or contributing author for abstracts, presentations, and manuscripts as appropriate

Minimum Qualifications:


  • MD, PhD or PharmD in life science/healthcare discipline expected. MD - Board Certified (or non-USA equivalent) in relevant field is preferred.
  • 5+ years of relevant clinical development experience in the pharmaceutical industry is expected including experience with study data review/evaluation
  • Clinical development industry experience with a working knowledge of pharmaceutical and regulatory development processes is essential
    Demonstrated program leadership capabilities in a matrixed environment
  • Demonstrated stakeholder management skills including risk mitigation
  • Proficient in project management terminology and processes to drive clinical development program risk mitigation strategies
  • Excellent analytical thinking and scientific/medical writing skills
  • Proficient in clinical data analysis and interpretation
  • Proven effective problem-solving skills and the ability to think critically and make informed decisions
  • Demonstrated effective communication and presentation skills
  • Proven ablility to build bridges and proactively improve cross-functional collaboration

The minimum and maximum base salary range that CSL expects to pay for this position at the Waltham, MA USA work location at the time of this posting is $317,000 - $409,000/yr. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.


#LI-HYBRID

Über CSL Behring

CSL Behring ist ein weltweit führender Anbieter von Biotherapeutika, angetrieben von unserem Versprechen, Leben zu retten. Wir konzentrieren uns darauf, die Bedürfnisse der Patienten durch den Einsatz der neuesten Technologien zu erfüllen. Wir entdecken, entwickeln und liefern innovative Therapien für Menschen, die mit Erkrankungen in den Therapiebereichen Immunologie, Hämatologie, Herz-Kreislauf und Stoffwechsel, Atemwegserkrankungen und Transplantation leben. Wir nutzen drei strategische wissenschaftliche Plattformen der Plasmafraktionierung, der rekombinanten Proteintechnologie sowie der Zell- und Gentherapie, um kontinuierliche Innovation zu unterstützen und die Wege zu verfeinern, auf denen Produkte ungedeckte medizinische Bedürfnisse ansprechen und Patienten zu einem erfüllten Leben verhelfen können.

CSL Behring betreibt eines der weltweit größten Plasma-Sammelnetzwerke, CSL Plasma. Unsere Muttergesellschaft CSL mit Hauptsitz in Melbourne, Australien, beschäftigt 32.000 Mitarbeiter und liefert ihre lebensrettenden Therapien an Menschen in mehr als 100 Ländern.

Um mehr über CSL, CSL Behring, CSL Seqirus und CSL Vifor zu erfahren, besuchen Sie https://www.csl.com/ und CSL Plasma unter https://www.cslplasma.com/.

Unsere Vorteile

Weitere Informationen zu den CSL-Vorteilen finden Sie unter How CSL Supports Your Well-being | CSL.

Sie gehören zu CSL

Bei CSL stehen Inklusion und Zugehörigkeit im Mittelpunkt unserer Mission und unserer Identität. Sie treiben unsere Innovation Tag für Tag an. Indem wir unsere Unterschiede feiern und eine Kultur der Neugier und Empathie schaffen, sind wir in der Lage, unsere Patienten und Spender besser zu verstehen und mit ihnen in Kontakt zu treten, starke Beziehungen zu unseren Stakeholdern zu pflegen und eine vielfältige Belegschaft aufrechtzuerhalten, die unser Unternehmen und unsere Branche in die Zukunft führen wird.

Um mehr über Inklusion und Zugehörigkeit zu erfahren, besuchen Sie https://www.csl.com/careers/inclusion-and-belonging

Arbeitgeber der Chancengleichheit

CSL ist ein Arbeitgeber der Chancengleichheit (Equal Opportunity Employer). Wenn Sie eine Person mit einer Behinderung sind und eine angemessene Vorkehrung für einen Teil des Bewerbungsprozesses benötigen, besuchen Sie bitte https://www.csl.com/accessibility-statement.

Standort